Lansoprazole and Myelitis - a phase IV clinical study of FDA data

Summary:

Myelitis is reported as a side effect among people who take Lansoprazole (lansoprazole), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Solu-Medrol, and have Bone marrow conditioning regimen.

The phase IV clinical study analyzes which people have Myelitis when taking Lansoprazole. It is created by eHealthMe based on reports of 128,069 people who have side effects when taking Lansoprazole from the FDA, and is updated regularly.

What is Lansoprazole?

Lansoprazole has active ingredients of lansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 129,663 Lansoprazole users. Check the latest studies of Lansoprazole.

What is Myelitis?

Myelitis (infection or the inflammation of white matter or gray matter of spinal cord which is a part of central nervous system) is found to be associated with 186 drugs and 340 conditions by eHealthMe. Check the latest studies of Myelitis.

On Jul, 16, 2026

128,069 people reported to have side effects when taking Lansoprazole.
Among them, 11 people (0.01%) have Myelitis.

Among these 11 people:

How long have people been on Lansoprazole when they have Myelitis? *

What is the gender of people who have Myelitis when taking Lansoprazole? *

female: 60 %
male: 40 %

What is the age of people who have Myelitis when taking Lansoprazole? *

What are other drugs people take besides Lansoprazole? *

What are other side effects people have besides Myelitis? *

Peripheral Sensory Neuropathy (damage to one or more of your peripheral nerves): 3 people, 27.27%
Meningitis Aseptic (a condition that causes the membranes covering your brain and spinal cord to become inflamed): 3 people, 27.27%
Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 3 people, 27.27%
Graft Versus Host Disease In Intestine (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body and damages intestinal mucosal membrane): 3 people, 27.27%
Drug Ineffective: 3 people, 27.27%
Rashes (redness): 2 people, 18.18%
Fever: 2 people, 18.18%
Back Pain: 2 people, 18.18%
Weakness: 1 person, 9.09%
Urinary Tract Infection: 1 person, 9.09%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 27.27%
Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 3 people, 27.27%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 27.27%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 27.27%
Bone Marrow Conditioning Regimen: 3 people, 27.27%
Osteoporosis (bones weak and more likely to break): 2 people, 18.18%
Malignant Melanoma (skin cancer rises from melancytes): 2 people, 18.18%
Multiple Myeloma (cancer of the plasma cells): 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Lansoprazole and have Myelitis?

- Check whether Myelitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lansoprazole:

Lansoprazole (129,663 reports)

Myelitis treatments and more:

Myelitis (2,018 reports)

Browse all side effects of Lansoprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Myelitis:

Myelitis (186 drugs)

Browse all the conditions that are associated with Myelitis:

Myelitis (340 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lansoprazole (the active ingredients of Lansoprazole) and Lansoprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.